Apollon Wealth Management, LLC Bio Line Rx Ltd. Transaction History

Apollon Wealth Management, LLC

  • $3.45 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
BUY
$0.88 - $1.91 $42,935 - $93,188
48,790 New
48,790 $45,000
Q2 2022

Aug 11, 2022
SELL
$1.06 - $1.82 $59,794 - $102,666
-56,410 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$1.46 - $2.18 $82,358 - $122,973
56,410 New
56,410 $96,000

Others Institutions Holding BLRX

# of Institutions
38
Shares Held
3.35M
Call Options Held
46.5K
Put Options Held
6.3K
View Full List

About BioLineRx Ltd.

BLRX Quotes by TradingView
  • Ticker BLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,524,500
  • Market Cap $13.5M
  • Description
  • BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...
More about BLRX
Track This Portfolio

Track Apollon Wealth Management, LLC Portfolio

Follow Apollon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email